» Articles » PMID: 24586123

Incident HIV During Pregnancy and Postpartum and Risk of Mother-to-child HIV Transmission: a Systematic Review and Meta-analysis

Overview
Journal PLoS Med
Specialty General Medicine
Date 2014 Mar 4
PMID 24586123
Citations 241
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Women may have persistent risk of HIV acquisition during pregnancy and postpartum. Estimating risk of HIV during these periods is important to inform optimal prevention approaches. We performed a systematic review and meta-analysis to estimate maternal HIV incidence during pregnancy/postpartum and to compare mother-to-child HIV transmission (MTCT) risk among women with incident versus chronic infection.

Methods And Findings: We searched PubMed, Embase, and AIDS-related conference abstracts between January 1, 1980, and October 31, 2013, for articles and abstracts describing HIV acquisition during pregnancy/postpartum. The inclusion criterion was studies with data on recent HIV during pregnancy/postpartum. Random effects models were constructed to pool HIV incidence rates, cumulative HIV incidence, hazard ratios (HRs), or odds ratios (ORs) summarizing the association between pregnancy/postpartum status and HIV incidence, and MTCT risk and rates. Overall, 1,176 studies met the search criteria, of which 78 met the inclusion criterion, and 47 contributed data. Using data from 19 cohorts representing 22,803 total person-years, the pooled HIV incidence rate during pregnancy/postpartum was 3.8/100 person-years (95% CI 3.0-4.6): 4.7/100 person-years during pregnancy and 2.9/100 person-years postpartum (p = 0.18). Pooled cumulative HIV incidence was significantly higher in African than non-African countries (3.6% versus 0.3%, respectively; p<0.001). Risk of HIV was not significantly higher among pregnant (HR 1.3, 95% CI 0.5-2.1) or postpartum women (HR 1.1, 95% CI 0.6-1.6) than among non-pregnant/non-postpartum women in five studies with available data. In African cohorts, MTCT risk was significantly higher among women with incident versus chronic HIV infection in the postpartum period (OR 2.9, 95% CI 2.2-3.9) or in pregnancy/postpartum periods combined (OR 2.3, 95% CI 1.2-4.4). However, the small number of studies limited power to detect associations and sources of heterogeneity.

Conclusions: Pregnancy and the postpartum period are times of persistent HIV risk, at rates similar to "high risk" cohorts. MTCT risk was elevated among women with incident infections. Detection and prevention of incident HIV in pregnancy/postpartum should be prioritized, and is critical to decrease MTCT.

Citing Articles

Preventing HIV in women in Africa.

Cowan F, Shahmanesh M, Revill P, Busza J, Sibanda E, Chabata S Nat Med. 2025; .

PMID: 39948405 DOI: 10.1038/s41591-025-03535-8.


Antiretroviral Use for HIV Prevention During Pregnancy: The Need to Strengthen Regulatory and Surveillance Systems in Africa.

Schaefer R, Donaldson L, Chigome A, Escudeiro Dos Santos M, Lamprianou S, Ndembi N Drug Saf. 2025; 48(3):209-216.

PMID: 39873899 PMC: 11829904. DOI: 10.1007/s40264-024-01494-6.


The effect of STI screening during pregnancy on vertical transmission of HIV and adverse pregnancy outcomes in South Africa: a modelling study.

Nyemba D, Joseph-Davey D, Delany-Moretlwe S, Myer L, Johnson L J Int AIDS Soc. 2025; 28(2):e26410.

PMID: 39865475 PMC: 11769709. DOI: 10.1002/jia2.26410.


Preferences for and acceptability of long-acting HIV prevention products among pregnant and lactating women accessing health services in Kenya: a mixed method cross-sectional analysis.

Ogello V, Mwangi P, Kwena Z, Thuo N, Makokha C, Owidi E BMC Infect Dis. 2025; 25(1):37.

PMID: 39773105 PMC: 11705746. DOI: 10.1186/s12879-024-10414-z.


Predictors of maternal HIV acquisition during pregnancy and lactation in sub-Saharan Africa: A systematic review and narrative synthesis.

Graybill L, Chi B, Hamoonga T, Kasaro M, Hodges J, Richardson B PLoS One. 2024; 19(12):e0314747.

PMID: 39625969 PMC: 11614209. DOI: 10.1371/journal.pone.0314747.


References
1.
Pando M, Gomez-Carrillo M, Vignoles M, Rubio A, dos Ramos Farias M, Vila M . Incidence of HIV type 1 infection, antiretroviral drug resistance, and molecular characterization in newly diagnosed individuals in Argentina: A Global Fund Project. AIDS Res Hum Retroviruses. 2010; 27(1):17-23. PMC: 3034098. DOI: 10.1089/aid.2010.0013. View

2.
Humphrey J, Hargrove J, Malaba L, Iliff P, Moulton L, Mutasa K . HIV incidence among post-partum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS. 2006; 20(10):1437-46. DOI: 10.1097/01.aids.0000233578.72091.09. View

3.
. The Joint United Nations Programme on HIV / AIDS (UNAIDS). Project update. Pac AIDS Alert Bull. 2002; (18):15-6. View

4.
Johnson L, Stinson K, Newell M, Bland R, Moultrie H, Davies M . The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2011; 59(4):417-25. PMC: 3378499. DOI: 10.1097/QAI.0b013e3182432f27. View

5.
Saphonn V, Parekh B, Dobbs T, Mean C, Bun L, Ly S . Trends of HIV-1 seroincidence among HIV-1 sentinel surveillance groups in Cambodia, 1999-2002. J Acquir Immune Defic Syndr. 2005; 39(5):587-92. PMC: 2903555. View